![Hikaru Saito](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hikaru Saito
Directeur/Membre du Conseil chez United Immunity Co. Ltd.
Postes actifs de Hikaru Saito
Sociétés | Poste | Début | Fin |
---|---|---|---|
Saisei Ventures LLC
![]() Saisei Ventures LLC Investment ManagersFinance Saisei Ventures LLC (Saisei Ventures) is a venture capital firm founded by Jonathan Yeh in 2020. The firm is headquartered in Cambridge, Massachusetts. | Private Equity Investor | 01/01/2023 | - |
United Immunity Co. Ltd.
![]() United Immunity Co. Ltd. Pharmaceuticals: MajorHealth Technology United Immunity Co. Ltd. is a Japanese company that specializes in pipeline nano technology and immunity fusion technology, specifically in the field of cancer immunotherapy. The company is based in Tsu, Japan and was founded in 2017 by Naozumi Harada, who has been the CEO since then. The company's diverse products, including "nano immunotherapy," have shown promising clinical results and research in the treatment of sex cancer. The company is currently recruiting a researcher in the cancer immunotherapy field to analyze the action mechanism of nanotechnology applied cancer evaluation and drug evaluation using immunological methods. The company's focus is on the development of treatment for the cause of cold tumor type cancer through the understanding of tumor-associated macrophages. | Directeur/Membre du Conseil | 01/08/2023 | - |
Historique de carrière de Hikaru Saito
Anciens postes connus de Hikaru Saito
Sociétés | Poste | Début | Fin |
---|---|---|---|
ASTELLAS PHARMA INC. | Corporate Officer/Principal | 01/10/2015 | 31/12/2022 |
Astellas Venture Management LLC
![]() Astellas Venture Management LLC Investment ManagersFinance Astellas Venture Management LLC (Astellas Venture Management) is a venture capital subsidiary of Astellas Pharma Inc founded in 2000. The firm is headquartered in San Francisco, California. | Private Equity Investor | 01/05/2017 | 31/03/2022 |
Catamaran Bio, Inc.
![]() Catamaran Bio, Inc. Financial ConglomeratesFinance Catamaran Bio, Inc. provides investment services. The company is headquartered in Delaware. | Directeur/Membre du Conseil | 01/11/2020 | 30/03/2022 |
Redona Therapeutics, Inc.
![]() Redona Therapeutics, Inc. BiotechnologyHealth Technology Redona Therapeutics, Inc.operates as a biotechnology company focused on the modulation of non- RNA (ncRNA) function to treat cancer and other human diseases. It uses small molecules to modulate expression levels of oncogenes and other proteins of significance in disease. The company was founded by George Daley, Richard Gregory, Frank Slack, and Piotr Sliz and is headquartered in Watertown, MA. | Directeur/Membre du Conseil | 01/04/2020 | 30/03/2022 |
Cleave Therapeutics, Inc.
![]() Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Directeur/Membre du Conseil | 01/10/2019 | 31/12/2021 |
TSCAN THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/11/2019 | 31/07/2021 |
Pykus Therapeutics, Inc.
![]() Pykus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Pykus Therapeutics, Inc. engages in the development of a dissolvable intraocular surgical device. It offers novel polymer that provides retinal tamponade. The company was founded by James Stefater and Tomasz Stryjewski and is headquartered in Boston, MA. | Directeur/Membre du Conseil | 01/06/2018 | 31/01/2021 |
Formation de Hikaru Saito
Tokyo Institute of Technology | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 8 |
Japon | 4 |
Opérationnelle
Director/Board Member | 6 |
Private Equity Investor | 2 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 6 |
Finance | 4 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
TSCAN THERAPEUTICS, INC. | Health Technology |
ASTELLAS PHARMA INC. | Health Technology |
Entreprise privées | 7 |
---|---|
Astellas Venture Management LLC
![]() Astellas Venture Management LLC Investment ManagersFinance Astellas Venture Management LLC (Astellas Venture Management) is a venture capital subsidiary of Astellas Pharma Inc founded in 2000. The firm is headquartered in San Francisco, California. | Finance |
Catamaran Bio, Inc.
![]() Catamaran Bio, Inc. Financial ConglomeratesFinance Catamaran Bio, Inc. provides investment services. The company is headquartered in Delaware. | Finance |
Cleave Therapeutics, Inc.
![]() Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Health Technology |
Pykus Therapeutics, Inc.
![]() Pykus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Pykus Therapeutics, Inc. engages in the development of a dissolvable intraocular surgical device. It offers novel polymer that provides retinal tamponade. The company was founded by James Stefater and Tomasz Stryjewski and is headquartered in Boston, MA. | Commercial Services |
Saisei Ventures LLC
![]() Saisei Ventures LLC Investment ManagersFinance Saisei Ventures LLC (Saisei Ventures) is a venture capital firm founded by Jonathan Yeh in 2020. The firm is headquartered in Cambridge, Massachusetts. | Finance |
United Immunity Co. Ltd.
![]() United Immunity Co. Ltd. Pharmaceuticals: MajorHealth Technology United Immunity Co. Ltd. is a Japanese company that specializes in pipeline nano technology and immunity fusion technology, specifically in the field of cancer immunotherapy. The company is based in Tsu, Japan and was founded in 2017 by Naozumi Harada, who has been the CEO since then. The company's diverse products, including "nano immunotherapy," have shown promising clinical results and research in the treatment of sex cancer. The company is currently recruiting a researcher in the cancer immunotherapy field to analyze the action mechanism of nanotechnology applied cancer evaluation and drug evaluation using immunological methods. The company's focus is on the development of treatment for the cause of cold tumor type cancer through the understanding of tumor-associated macrophages. | Health Technology |
Redona Therapeutics, Inc.
![]() Redona Therapeutics, Inc. BiotechnologyHealth Technology Redona Therapeutics, Inc.operates as a biotechnology company focused on the modulation of non- RNA (ncRNA) function to treat cancer and other human diseases. It uses small molecules to modulate expression levels of oncogenes and other proteins of significance in disease. The company was founded by George Daley, Richard Gregory, Frank Slack, and Piotr Sliz and is headquartered in Watertown, MA. | Health Technology |
- Bourse
- Insiders
- Hikaru Saito
- Expérience